BRIEF-Aurinia releases open-label AURION data for Voclosporin

Thu Oct 6, 2016 8:37am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 6 (Reuters) - Aurinia Pharmaceuticals Inc :

* Label AURION data demonstrating increased remission rates over time for Voclosporin in the treatment of Lupus Nephritis

* Complete remission rates increase to 70 pct in open-label study at 24 weeks

* Patients in remission at eight weeks remained in remission at 24 weeks Source text for Eikon: Further company coverage: